PerkinElmer Posts 3 Percent Q4 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer reported after the market close on Thursday that its fourth quarter revenues increased 3 percent year over year, with growth driven by the firm's environmental health segment.

The Waltham, Mass.-based firm reported total revenues of $608.4 million, up from $591.9 million for the fourth quarter of 2013. It beat the consensus Wall Street estimate of $600 million. The firm also noted that on an organic basis its revenues were up 5 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.